- GLP-validated, high-throughput, 3D-bioprinted platforms for relevant toxicological and pharmacological endpoints
- Quantitative in vitro-in vivo extrapolation (QIVIVE): “what in vivo phenotype is your in vitro system relevant for, and how much?”
- Characterisation of the mechanism of action (MOA) of exposures. Relevant for DESIGN of new compounds! (TOXICOGENOMICS)
- Selection of relevant positive/negative chemical test items via AI-based computational approaches (QSAR, read-across, virtual screening)
